MoonLake Immunotherapeutics

MLTX

MoonLake Immunotherapeutics

MLTX

Insider Sentiment (TTM):

Last Purchase:2025-10-08Last Sale:2026-06-22Shares Purchased (TTM):10,870Shares Sold (TTM):4,060,526

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:59,847,258Shares Outstanding:71,273,650Institutional Ownership Pct.:83.97%

Earnings Market Reaction:

Filing Date:2026-08-10Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Common Class A	-	0	72	0	0	63	0	0	0	63	0	0
Common Class C	-	-	0	-0	0	1	0	-0	0	1	0	-0
Common Stock	-	-	-	64	-63	63	-	0	0	63	-	-
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	478	298	335	351	307	272	180	376	343	458	451	318
Available For Sale Securities Debt Securities Curr…	59	59	59	30	118	209	268	118	177	89	60	178
Other Receivables Net Current	7	6	5	4	3	3	3	2	2	1	1	1
Prepaid Expense Current	26	33	23	27	27	23	23	16	15	5	2	3
Assets Current	570	397	422	411	455	506	474	512	537	554	514	500
Assets Noncurrent
Operating Lease Right Of Use Asset	2	2	2	2	2	3	3	3	3	4	4	0
Prepaid Expense Noncurrent	-	-	-	-	-	-	0	2	4	6	8	-
Property Plant And Equipment Net	0	1	1	1	1	1	1	1	0	1	0	0
Other Assets Noncurrent	1	1	1	1	2	2	0	-	-	-	-	-
Assets Noncurrent	4	4	3	3	5	5	4	6	8	11	12	0
Assets	574	400	424	414	460	511	478	518	545	564	527	500
Liabilities And Stockhold…
Liabilities Current
Accrued Liabilities And Other Liabilities	27	22	15	22	9	11	12	8	6	4	7	7
Operating Lease Liability Current	1	1	1	1	2	1	1	1	1	1	1	0
Liabilities Current	45	46	45	48	27	24	22	20	12	9	10	10
Liabilities Noncurrent
Long Term Debt	100	99	74	74	73	73	0	-	-	-	-	-
Operating Lease Liability Noncurrent	1	1	0	0	1	1	1	2	2	2	2	0
Defined Benefit Pension Plan Liabilities Noncurren…	0	0	0	1	1	1	1	1	1	0	1	0
Liabilities Noncurrent	100	100	74	75	75	75	2	3	3	3	3	0
Liabilities	146	146	120	123	102	99	25	23	15	12	13	11
Equity
Additional Paid In Capital	1,022	786	767	689	684	681	677	675	672	670	610	531
Retained Earnings Accumulated Deficit	-594	-533	-463	-400	-331	-276	-236	-190	-155	-130	-117	-109
Accumulated Other Comprehensive Income Loss Net Of…	1	0	1	0	1	2	5	3	3	3	2	3
Stockholders Equity	428	254	304	291	354	408	447	496	530	552	496	425
Minority Interest	-	-	0	2	4	5	7	7	9	10	18	65
Liabilities And Stockholders Equity	574	400	424	414	460	511	478	518	545	564	527	500

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-4.99%	0.58%	-2.12%	-	-	-	-	-	-	-	-	-
2025	16.67%	21.68%	31.71%	4.38%	16.06%	-82.18%	29.65%	30.59%	49.76%	-10.70%	0.66%	-3.68%
2024	-6.87%	0.71%	2.54%	8.66%	14.72%	8.45%	7.42%	9.28%	-9.81%	-5.31%	-9.55%	-11.21%
2023	-	-	-	-	-	-	48.13%	46.20%	47.73%	7.79%	-12.54%	-17.60%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	12.56	8.60	9.27	8.50	16.65	21.11	21.11	25.51	43.71	62.13	51.59	48.51
Quick Ratio	11.98	7.89	8.77	7.95	15.66	20.15	20.07	24.72	42.46	61.56	51.38	48.19
Working Capital	524.65M	350.53M	376.22M	362.85M	428.12M	482.28M	451.83M	492.24M	524.60M	544.68M	504.20M	489.70M
Leverage & Debt
Debt to Equity	0.34	0.58	0.39	0.42	0.29	0.24	0.05	0.05	0.03	0.02	0.03	0.02
Interest Coverage TTM	-26.58	-28.15	-33.78	-43.63	-97.75	-9,486.44	-	-	-	-	-	-
Debt Ratio	0.25	0.37	0.28	0.30	0.22	0.19	0.05	0.04	0.03	0.02	0.02	0.02
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-3.57	-3.61	-3.53	-3.30	-2.77	-2.29	-1.89	-1.35	-0.93	-0.73	-0.90	-0.76
Free Cash Flow Per Share TTM	-2.67	-3.15	-3.04	-2.33	-2.03	-2.22	-1.86	-1.29	-1.03	-0.79	-0.88	-0.79
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	50.35%	77.41%	91.13%	146.07%	201.11%	216.14%	169.82%	109.37%	41.19%	-1.03%	19.79%	-17.25%
EPS Growth (1Y)	28.72%	57.40%	86.40%	144.23%	199.16%	213.16%	110.82%	78.15%	-1.82%	-38.28%	-28.40%	-42.90%
Valuation Metrics
P/E TTM	-5.46	-5.17	-3.74	-2.17	-17.03	-17.05	-28.62	-37.34	-47.47	-68.64	-67.30	-75.20
P/B TTM	3.36	5.23	2.79	1.56	8.44	6.06	7.51	6.40	5.22	5.70	5.78	7.18
Market Cap	1.44B	1.33B	849.63M	454.36M	2.99B	2.47B	3.40B	3.17B	2.76B	3.15B	2.97B	3.05B
Enterprise Value	1.06B	1.13B	589.22M	177.37M	2.75B	2.27B	3.22B	2.80B	2.42B	2.69B	2.52B	2.73B
Calculated Values
Free Cash Flow TTM	-197.07M	-224.22M	-196.11M	-147.79M	-128.66M	-140.12M	-117.11M	-81.09M	-64.93M	-49.20M	-43.06M	-42.03M
Net Debt	-378.39M	-199.47M	-260.42M	-277.00M	-233.30M	-198.54M	-180.43M	-375.66M	-342.79M	-458.44M	-451.17M	-318.17M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-22Sale

Owner: Bodenstedt, Matthias

Title: Chief Financial Officer

Shares: 39,120

Price/Share: $22.04

Value: $862,204.80

Shares Owned: 1,115,435

Relationship: Officer

Ownership: Direct

2026-06-18Sale

Owner: Bodenstedt, Matthias

Title: Chief Financial Officer

Shares: 2,794

Price/Share: $19.60

Value: $54,762.40

Shares Owned: 1,154,555

Relationship: Officer

Ownership: Direct

2026-06-17Sale

Owner: Reich, Kristian

Title: Chief Scientific Officer

Shares: 50,000

Price/Share: $19.43

Value: $971,500.00

Shares Owned: 2,824,551

Relationship: Officer

Ownership: Indirect

2026-05-11Sale

Owner: Bodenstedt, Matthias

Title: Chief Financial Officer

Shares: 13,653

Price/Share: $20.02

Value: $273,333.06

Shares Owned: 1,172,431

Relationship: Officer

Ownership: Direct

2026-04-14Sale

Owner: Bodenstedt, Matthias

Title: Chief Financial Officer

Shares: 2,426

Price/Share: $19.56

Value: $47,452.56

Shares Owned: 1,186,084

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-22	Bodenstedt, Matthias	Officer	Chief Financial Officer	Direct	Sale	39,120	22.04	$862,204.80	1,115,435	4
2026-06-18	Bodenstedt, Matthias	Officer	Chief Financial Officer	Direct	Sale	2,794	19.60	$54,762.40	1,154,555	4
2026-06-17	Reich, Kristian	Officer	Chief Scientific Officer	Indirect	Sale	50,000	19.43	$971,500.00	2,824,551	4
2026-05-11	Bodenstedt, Matthias	Officer	Chief Financial Officer	Direct	Sale	13,653	20.02	$273,333.06	1,172,431	4
2026-04-14	Bodenstedt, Matthias	Officer	Chief Financial Officer	Direct	Sale	2,426	19.56	$47,452.56	1,186,084	4
2026-04-13	Santos, Da Silva Jorge	Director,Officer	Chief Executive Officer	Direct	Sale	51,873	18.23	$945,644.79	2,924,893	4
2026-04-10	Bodenstedt, Matthias	Officer	Chief Financial Officer	Direct	Sale	1,925	19.51	$37,556.75	1,188,510	4
2026-03-31	Lampert, Mark N, Bvf Ii G…	Director,TenPercentOwner	-	Direct	Sale	3,750,000	16.79	$62,962,500.00	1,039,238	4
2025-12-09	Reich, Kristian	Officer	Chief Scientific Officer	Direct	Sale	72,908	14.43	$1,052,062.44	0	4
2025-12-09	Santos, Da Silva Jorge	Director,Officer	Chief Executive Officer	Direct	Sale	70,000	14.49	$1,014,300.00	2,878,577	4
2025-10-08	Bodenstedt, Matthias	Officer	Chief Financial Officer	Direct	Purchase	10,870	9.09	$98,808.30	627,536	4
2025-09-30	Cormorant, Global Healthc…	Other	-	Indirect	Sale	5,827	6.96	$40,555.92	1,994,173	4
2025-07-03	Moukheibir, Catherine	Director	-	Direct	Sale	23,500	48.79	$1,146,565.00	0	4
2024-10-04	Sturge, Simon	Director	-	Direct	Sale	171,000	53.72	$9,186,120.00	171,980	4
2024-10-04	Bvf, I Gp Llc, Lampert Ma…	Director,TenPercentOwner	-	Direct	Sale	2,000,000	50.00	$100,000,000.00	1,287,768	4
2024-02-29	Santos, Da Silva Jorge	Director,Officer	Chief Executive Officer	Direct	Sale	4,740	55.89	$264,918.60	2,982,814	4
2024-02-28	Reich, Kristian	Officer	Chief Scientific Officer	Direct	Sale	28,090	55.00	$1,544,950.00	41,981	4
2024-02-21	Santos, Da Silva Jorge	Director,Officer	Chief Executive Officer	Direct	Sale	1,125	55.27	$62,178.75	3,106,429	4
2024-02-21	Reich, Kristian	Officer	Chief Scientific Officer	Direct	Sale	569	55.30	$31,465.70	99,502	4
2024-02-20	Santos, Da Silva Jorge	Director,Officer	Chief Executive Officer	Direct	Sale	20,000	57.44	$1,148,800.00	3,107,554	4
2024-02-16	Reich, Kristian	Officer	Chief Scientific Officer	Direct	Sale	10,000	60.15	$601,500.00	110,071	4
2023-12-20	Bodenstedt, Matthias	Officer	Chief Financial Officer	Direct	Sale	5,264	58.34	$307,101.76	520,903	4
2023-10-05	Cormorant, Private Health…	TenPercentOwner	-	Indirect	Purchase	58,839	59.90	$3,524,456.10	8,494,151	4
2023-10-04	Cormorant, Private Health…	TenPercentOwner	-	Indirect	Purchase	67,814	57.32	$3,887,098.48	8,435,312	4
2023-06-30	Chen, Bihua	TenPercentOwner	-	Indirect	Purchase	800,000	50.00	$40,000,000.00	4,927,100	4
2023-06-26	Chen, Bihua	TenPercentOwner	-	Indirect	Purchase	450,000	52.64	$23,688,000.00	4,127,100	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

83.97%

Inst. Shares: 59,847,258

Shares Outstanding: 71,273,650

2025-12-31

84.14%

Inst. Shares: 54,240,366

Shares Outstanding: 64,463,889

2025-09-30

57.40%

Inst. Shares: 36,377,035

Shares Outstanding: 63,369,984

2025-06-30

88.26%

Inst. Shares: 55,850,986

Shares Outstanding: 63,282,728

2025-03-31

89.00%

Inst. Shares: 56,275,090

Shares Outstanding: 63,233,788

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	59,847,258	71,273,650	83.97%
2025-12-31	54,240,366	64,463,889	84.14%
2025-09-30	36,377,035	63,369,984	57.40%
2025-06-30	55,850,986	63,282,728	88.26%
2025-03-31	56,275,090	63,233,788	89.00%
2024-12-31	59,337,129	62,870,237	94.38%
2024-09-30	58,484,757	62,896,782	92.99%
2024-06-30	57,625,719	62,874,637	91.65%
2024-03-31	55,582,638	62,637,212	88.74%
2023-12-31	53,857,613	49,122,534	109.64%
2023-09-30	52,293,729	53,517,655	97.71%
2023-06-30	51,484,484	43,718,464	117.76%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

MoonLake Immunotherapeutics (MLTX) — SEC Financial Statements & Analysis

MoonLake Immunotherapeutics (MLTX) is a pharmaceutical preparations company, incorporated in E9. MoonLake Immunotherapeutics trades on Nasdaq as: MLTX. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), MoonLake Immunotherapeutics reported a Debt-to-Equity ratio of 0.34x, a Price-to-Book (P/B) ratio of 3.36x (TTM), at a market cap of $1.44B. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 0.34x
P/B TTM: 3.36x
Market Cap: $1.44B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is MoonLake Immunotherapeutics in?

MoonLake Immunotherapeutics (MLTX) operates in the Pharmaceutical Preparations industry.

What is MLTX's market cap?

MoonLake Immunotherapeutics (MLTX) has a market capitalization of $1.44B as of 2026-06-30.

What exchange does MLTX trade on?

MoonLake Immunotherapeutics (MLTX) trades on the Nasdaq.

Where is MoonLake Immunotherapeutics incorporated?

MoonLake Immunotherapeutics is incorporated in Cayman Islands.